Javascript is disabled in your browser. Please enable Javascript to view PeerJ.

January 2022

Table of Contents - PeerJ (Medicine Articles)

January 25, 2022

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer

Yichi Zhang, Yifeng Lin, Daojun Lv, Xiangkun Wu, Wenjie Li, Xueqing Wang, Dongmei Jiang

https://doi.org/10.7717/peerj.12843 PubMed 35127296

January 3, 2022

Role of miR-100-5p and CDC25A in breast carcinoma cells

Xiaoping Li, Yanli Ren, Donghong Liu, Xi Yu, Keda Chen

https://doi.org/10.7717/peerj.12263 PubMed 35036112

January 13, 2022

Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma

Supharada Tessiri, Anchalee Techasen, Sarinya Kongpetch, Achira Namjan, Watcharin Loilome, Waraporn Chan-on, Raynoo Thanan, Apinya Jusakul

https://doi.org/10.7717/peerj.12750 PubMed 35070505

January 4, 2022

Key genes associated with prognosis and metastasis of clear cell renal cell carcinoma

Tingting Zhong, Zeying Jiang, Xiangdong Wang, Honglei Wang, Meiyi Song, Wenfang Chen, Shicong Yang

https://doi.org/10.7717/peerj.12493 PubMed 35036081

January 26, 2022

miR-148a-3p inhibits the proliferation and migration of bladder cancer via regulating the expression of ROCK-1

Chao Xu, Guanwen Zhou, Zhuang Sun, Zhaocun Zhang, Haifeng Zhao, Xianzhou Jiang

https://doi.org/10.7717/peerj.12724 PubMed 35127282

January 5, 2022

Identification of FEZ2 as a potential oncogene in pancreatic ductal adenocarcinoma

Chaozhi Yang, Xuebing Wang, Chenjie Qiu, Ziruo Zheng, Kai Lin, Min Tu, Kai Zhang, Kuirong Jiang, Wentao Gao

https://doi.org/10.7717/peerj.12736 PubMed 35036176

← Previous
1
Next →